Senmiao Technology Ltd (AIHS): Nasdaq/NYSE listing notice — Senmiao Technology receives Nasdaq bid price deficiency notice; 1:10 reverse split effectuated

Senmiao Technology Ltd

Nasdaq notice on July 29, 2025: stock failed $1 minimum bid price for 30 consecutive business days.
Company has 180 days (until Jan 26, 2026) to regain compliance by closing at $1+ for 10 straight days.
Reverse stock split 1:10 effectuated July 29, 2025 to help meet bid price requirement.
If not cured, may qualify for second 180-day period or face delisting and appeal process.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Senmiao Technology Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

July 29, 2025, Senmiao Technology Limited (the “Company”) received a deficiency notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that its common stock, par value $0.0001 per share (the “Common Stock”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital Market. Pursuan

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Senmiao Technology Ltd filing history →

Source: SEC EDGAR

accession 0001213900-25-070602

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.